Research Group
Cancer Biomarkers
Sponsor
City of Hope Medical Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03303846
This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.
Intervention
Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis
Condition
Healthy Subject
Investigators
Victoria Seewaldt, MD, Julie E. Lang, MD, Ruth O'Regan, MD, Terry Hyslop, PhD, Steven K. Clinton, MD, Lisa Yee, MD, Renae Quale, Tanya Chavez, Sarah Woelke, Kristy Watkins, Jennifer Gallagher